BioregulatorResearch
Bonothyrk
Also known as: A-21 · Parathyroid Cytomax
A Cytomax parathyroid bioregulator for mineral balance, osteoporosis prevention, and arterial calcification defense.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
Per bioregulator protocol
Administration
Oral capsule
Mechanism of Action
Parathyroid-derived peptide complex that normalizes calcium metabolism and drives mineral resorption into bone.
Key Research Areas
bioregulatorparathyroidcalciumosteoporosis
Frequently Asked Questions
What is Bonothyrk?▾
A Cytomax parathyroid bioregulator for mineral balance, osteoporosis prevention, and arterial calcification defense.
How does Bonothyrk work?▾
Parathyroid-derived peptide complex that normalizes calcium metabolism and drives mineral resorption into bone.
What is the recommended dosage for Bonothyrk?▾
The typical research dosage is Per bioregulator protocol, administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Bonothyrk?▾
The half-life of Bonothyrk is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Bonothyrk FDA approved?▾
Bonothyrk is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Bonothyrk is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.